发明授权
US07887833B2 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting
有权
两性化合物和囊泡脂质体用于器官特异性药物靶向
- 专利标题: Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting
- 专利标题(中): 两性化合物和囊泡脂质体用于器官特异性药物靶向
-
申请号: US10497705申请日: 2002-12-04
-
公开(公告)号: US07887833B2公开(公告)日: 2011-02-15
- 发明人: Eliahu Heldman , Charles Linder , Sarina Grinberg , Victoria Kolot , Eleonora Shaubi
- 申请人: Eliahu Heldman , Charles Linder , Sarina Grinberg , Victoria Kolot , Eleonora Shaubi
- 申请人地址: IL Beer-Sheva
- 专利权人: Ben-Gurion University of the Negev Research and Development Authority
- 当前专利权人: Ben-Gurion University of the Negev Research and Development Authority
- 当前专利权人地址: IL Beer-Sheva
- 代理机构: Browdy and Neimark, PLLC
- 国际申请: PCT/IL02/00977 WO 20021204
- 国际公布: WO03/047499 WO 20030612
- 主分类号: A61K9/127
- IPC分类号: A61K9/127 ; C07C231/00 ; C07C229/00
摘要:
An amphiphilic compound is provided capable of forming vesicles or liposomes, said amphiphilic compound having at least one headgroup containing a selectively cleavable group or moiety such as a residue of a choline or phenylalanine derivative, and at least one hydrogen-bonding group located either within said headgroup and/or in close proximity thereto. The cleavable group or moiety is cleaved under selective conditions including change of chemical, physical or biological environment and is preferably cleaved enzymatically in a biological environment such as the brain or the blood. Vesicles or liposomes made from said amphiphilic compounds are suitable for delivery of a therapeutic substance or a diagnostic agent specifically to a target organ or tissue, or for delivery of a nucleic acid for gene therapy.
公开/授权文献
信息查询